NewsBenzingaGenmab anuncia que Darwin Global Management ahora controla 3.188.361 acciones, el 5,11 % de los derechos de voto Genmab anuncia que Darwin Global Management ahora controla 3.188.361 acciones, el 5,11 % de los derechos de voto Benzinga 2026.10.02 17:57 (GMT+0) Open on Benzinga Other news UBS Maintains Neutral on CVR Energy, Raises Price Target to $53 UBS Maintains Neutral on Nike, Lowers Price Target to $34 Eli Lilly Says FDA Approves Additional Indication For Jaypirca, Non-Covalent BTK Inhibitor, For Treatment Of Adult Patients With Previously Untreated Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma Dear Tesla Stock Fans, Mark Your Calendars for October 15 UBS Maintains Buy on Expeditors International, Raises Price Target to $220 The Joint U.S.-Ukrainian Reconstruction Investment Fund Has Sealed Its First Critical Minerals Deal Alongside Four Other New Projects
Eli Lilly Says FDA Approves Additional Indication For Jaypirca, Non-Covalent BTK Inhibitor, For Treatment Of Adult Patients With Previously Untreated Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma
The Joint U.S.-Ukrainian Reconstruction Investment Fund Has Sealed Its First Critical Minerals Deal Alongside Four Other New Projects
